Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Bloem LT"'
Autor:
Taams AC; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Dutch Medicines Evaluation Board, Utrecht, The Netherlands., Herberts CA; Dutch Medicines Evaluation Board, Utrecht, The Netherlands., Egberts ACG; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, The Netherlands., Zafiropoulos N; European Medicines Agency, Amsterdam, The Netherlands., Pignatti F; European Medicines Agency, Amsterdam, The Netherlands., Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. Electronic address: l.t.bloem@uu.nl.
Publikováno v:
ESMO open [ESMO Open] 2024 Dec 09; Vol. 9 (12), pp. 103991. Date of Electronic Publication: 2024 Dec 09.
Autor:
Zinken JF; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands; Dutch Medicines Evaluation Board (CBG-MEB), Utrecht, the Netherlands., Pasmooij AMG; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands; Dutch Medicines Evaluation Board (CBG-MEB), Utrecht, the Netherlands., Ederveen AGH; Dutch Medicines Evaluation Board (CBG-MEB), Utrecht, the Netherlands., Hoekman J; Innovation Studies, Copernicus Institute of Sustainable Development, Utrecht University, Utrecht, the Netherlands., Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands. Electronic address: l.t.bloem@uu.nl.
Publikováno v:
Drug discovery today [Drug Discov Today] 2024 Dec; Vol. 29 (12), pp. 104213. Date of Electronic Publication: 2024 Oct 18.
Autor:
Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands; Regulatory Science Network Netherlands, Utrecht, the Netherlands. Electronic address: l.t.bloem@uu.nl., Leufkens HGM; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Berends SE; Regulatory Science Network Netherlands, Utrecht, the Netherlands; Lygature, Utrecht, the Netherlands., Vreman RA; Roche Netherlands B.V, Woerden, the Netherlands., Hollak CEM; Department of Endocrinology and Metabolism, Amsterdam UMC, Amsterdam, the Netherlands., van Weely S; ZonMw, The Hague, the Netherlands., de Lannoy LM; Independent Patient Advocate, the Netherlands., Bertens PJA; Association Innovative Medicines, The Hague, the Netherlands., Pasmooij AMG; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands; Regulatory Science Network Netherlands, Utrecht, the Netherlands; Dutch Medicines Evaluation Board, Utrecht, the Netherlands. Electronic address: a.m.g.pasmooij@uu.nl.
Publikováno v:
Drug discovery today [Drug Discov Today] 2024 Nov 26, pp. 104251. Date of Electronic Publication: 2024 Nov 26.
Autor:
van Hattem CC; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.; Medicines Evaluation Board, Utrecht, the Netherlands., de Jong AJ; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., de Groot JS; Medicines Evaluation Board, Utrecht, the Netherlands., Hoekman J; Innovation Studies, Copernicus Institute of Sustainable Development, Utrecht University, Utrecht, the Netherlands., Broekman KE; Medicines Evaluation Board, Utrecht, the Netherlands.; Department of Medical Oncology, University Medical Centre Groningen, Groningen, the Netherlands., Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, University of Amsterdam, Amsterdam, the Netherlands., van Hennik PB; Medicines Evaluation Board, Utrecht, the Netherlands., Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands L.T.Bloem@uu.nl.
Publikováno v:
BMJ open [BMJ Open] 2024 Nov 09; Vol. 14 (11), pp. e084483. Date of Electronic Publication: 2024 Nov 09.
Autor:
Stoelinga J; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; School of Pharmacy, Utrecht University, Utrecht, the Netherlands., Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Russo M; Department of Statistics, the Ohio State University, Columbus, OH, USA., Kesselheim AS; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Feldman WB; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: wbfeldman@bwh.harvard.edu.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Nov; Vol. 212, pp. 114330. Date of Electronic Publication: 2024 Sep 12.
Autor:
Jadoenathmisier KD; Dutch Medicines Evaluation Board, Utrecht, the Netherlands., Stoyanova-Beninska V; Dutch Medicines Evaluation Board, Utrecht, the Netherlands., Soons IM; National IT Institute for Healthcare (Nictiz), the Hague, the Netherlands., Leufkens HG; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands. Electronic address: l.t.bloem@uu.nl., Pasmooij AM; Dutch Medicines Evaluation Board, Utrecht, the Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2024 Nov 01; Vol. 202, pp. 106871. Date of Electronic Publication: 2024 Aug 05.
Autor:
Ogar CK; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Gilbert HN; Harvard Medical School, Department of Global Health and Social Medicine, USA., Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Leopold C; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Bassi PU; Department of Internal Medicine, College of Health Sciences, University of Abuja, Abuja, Nigeria., Katagum YM; Department of Clinical Pharmacy & Pharmacy Administration, Bauchi State University, Gadau. Nigeria., Osakwe AI; A - Line Pharmaceutical, Nsukka, Enugu, State, Nigeria., Opadeyi AO; Department of Clinical Pharmacology and Therapeutics, College of Medical Sciences, University of Benin/University of Benin Teaching Hospital, Benin-City, Nigeria., Oreagba I; Department of Pharmacology, Therapeutics and Toxicology College of Medicine University of Lagos, Lagos, Nigeria., Mbo DND; Department of Internal Medicine, Maitama District Hospital, Abuja, Nigeria., Mantel-Teeuwisse AK; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., De Bruin ML; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands. Electronic address: M.L.deBruin@uu.nl.
Publikováno v:
Vaccine [Vaccine] 2024 Oct 03; Vol. 42 (23), pp. 126196. Date of Electronic Publication: 2024 Aug 22.
Autor:
Verschueren MV; Department of Clinical Pharmacy, St Antonius Hospital, Utrecht, the Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Abedian Kalkhoran H; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, the Netherlands.; Department of Pharmacy, Haga Teaching Hospital, The Hague, the Netherlands., Deenen M; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, the Netherlands.; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, the Netherlands., van den Borne BEEM; Department of Respiratory Medicine, Catharina Hospital, Eindhoven, the Netherlands., Zwaveling J; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, the Netherlands., Visser LE; Department of Pharmacy, Haga Teaching Hospital, The Hague, the Netherlands.; Department of Hospital Pharmacy, Erasmus Medical Centre, Rotterdam, the Netherlands.; Department of Epidemiology, Erasmus Medical Centre, Rotterdam, the Netherlands., Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Peters BJM; Department of Clinical Pharmacy, St Antonius Hospital, Utrecht, the Netherlands., van de Garde EMW; Department of Clinical Pharmacy, St Antonius Hospital, Utrecht, the Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
Publikováno v:
JCO clinical cancer informatics [JCO Clin Cancer Inform] 2024 Oct; Vol. 8, pp. e2400053. Date of Electronic Publication: 2024 Oct 04.
Autor:
Hogervorst MA; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands., Soman KV; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands., Gardarsdottir H; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands; Division Laboratory and Pharmacy, Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands; Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavik, Iceland., Goettsch WG; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands; National Health Care Institute (ZIN), Diemen, The Netherlands., Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands. Electronic address: l.t.bloem@uu.nl.
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2024 Sep 04. Date of Electronic Publication: 2024 Sep 04.
Autor:
Sadreghaemy M; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands., Gamba MA; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands., Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands., Egberts TCG; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Aug; Vol. 33 (8), pp. e5868.